Merryl Cramer
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Receptor Mechanisms and Signaling 4
- RNA Interference and Gene Delivery 2
-
- Neuroscience and Neuropharmacology Research 11
- Co-authors
- Michael F. Gardner (4 shared papers)Shripad S. Bhagwat (3 shared papers)Joyce James (4 shared papers)Kelly G. Sprankle (2 shared papers)Hitesh Patel (2 shared papers)Ruwanthi N. Gunawardane (2 shared papers)Patrick P. Zarrinkar (2 shared papers)Qi Chao (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (11 papers)Blood (1 paper)Drug Metabolism and Disposition (1 paper)Journal of Medicinal Chemistry (1 paper)Neuroscience Letters (1 paper)
- Partner nations
- United States
In The Last Decade
Merryl Cramer
16 papers receiving 836 citations
Merryl Cramer's Hit Papers
Peers
Comparison fields: 5 of 62
- Hematology 437
- Genetics 191
- Cellular and Molecular Neuroscience 118
- Molecular Biology 410
- Organic Chemistry 153
Countries citing papers authored by Merryl Cramer
This map shows the geographic impact of Merryl Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merryl Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merryl Cramer more than expected).
Fields of papers citing papers by Merryl Cramer
This network shows the impact of papers produced by Merryl Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merryl Cramer. The network helps show where Merryl Cramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Merryl Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML) Hit paper breakdown → | 2009 | 479 |
| 2 | 2009 | 170 | |
| 3 | 2004 | 41 | |
| 4 | 2005 | 36 | |
| 5 | 2004 | 25 | |
| 6 | 2004 | 19 | |
| 7 | 2004 | 14 | |
| 8 | 2011 | 13 | |
| 9 | 2004 | 12 | |
| 10 | 2005 | 11 | |
| 11 | 2005 | 10 | |
| 12 | 2005 | 10 | |
| 13 | 2005 | 6 | |
| 14 | 2005 | 4 | |
| 15 | 2005 | 3 | |
| 16 | 2005 | 1 |
About Merryl Cramer
Merryl Cramer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Genetics, Genetics and Oncology, having authored 16 papers that have together received 854 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (4 papers), Genetics and Neurodevelopmental Disorders (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Adenosine and Purinergic Signaling (2 papers), RNA Interference and Gene Delivery (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (437 citations), Genetics (191 citations), Cellular and Molecular Neuroscience (118 citations), Molecular Biology (410 citations) and Organic Chemistry (153 citations). Merryl Cramer has collaborated with scholars based in United States. Frequent co-authors include Michael F. Gardner, Shripad S. Bhagwat, Joyce James, Kelly G. Sprankle, Hitesh Patel, Ruwanthi N. Gunawardane, Patrick P. Zarrinkar, Qi Chao, Robert C. Armstrong and Barbara Belli. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Blood, Drug Metabolism and Disposition, Journal of Medicinal Chemistry and Neuroscience Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.